← Back to headlines



Mindrank AI CEO Discusses Business Strategy and AI Drug Discovery
The founder and CEO of AI biotech firm Mindrank AI outlines the company's strategic focus on leveraging artificial intelligence for pharmaceutical development.
26 Aug, 03:53 — 26 Aug, 03:53
Related Stories

Pro-Russian Hackers Claim Responsibility for Major Cyberattacks on Norway
25m ago

Bill Gates Warns AI Is Humanity’s Most Dangerous Tool, Urges Global Regulation
30m ago

Boston Scientific Cyberattack Disrupts Global Operations and Slumps Shares
38m ago

HP and Huawei Sign Global Cross-Licensing Agreement for Wi-Fi Patents
43m ago